Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -103.56 Million USD | 36.75% |
| 2022 | -163.73 Million USD | 21.6% |
| 2021 | -208.85 Million USD | -3.42% |
| 2020 | -201.95 Million USD | -5.56% |
| 2019 | -191.32 Million USD | 2.7% |
| 2018 | -196.63 Million USD | -37.55% |
| 2017 | -142.95 Million USD | -53.96% |
| 2016 | -92.85 Million USD | -41.13% |
| 2015 | -65.79 Million USD | -17.02% |
| 2014 | -56.22 Million USD | -1857.59% |
| 2013 | -2.87 Million USD | 53.5% |
| 2012 | -6.17 Million USD | -207.92% |
| 2011 | 5.72 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -80.04 Million USD | -47.99% |
| 2024 Q1 | -54.08 Million USD | 47.78% |
| 2023 FY | -103.56 Million USD | 36.75% |
| 2023 Q1 | -141.38 Million USD | 13.65% |
| 2023 Q2 | -145.8 Million USD | -3.13% |
| 2023 Q3 | -101.84 Million USD | 30.15% |
| 2023 Q4 | -103.56 Million USD | -1.7% |
| 2022 Q2 | -198.43 Million USD | -5.78% |
| 2022 Q3 | -185.48 Million USD | 6.53% |
| 2022 Q4 | -163.73 Million USD | 11.73% |
| 2022 FY | -163.73 Million USD | 21.6% |
| 2022 Q1 | -187.58 Million USD | 10.18% |
| 2021 Q1 | -201.1 Million USD | 0.42% |
| 2021 FY | -208.85 Million USD | -3.42% |
| 2021 Q4 | -208.85 Million USD | 2.38% |
| 2021 Q3 | -213.93 Million USD | -1.69% |
| 2021 Q2 | -210.37 Million USD | -4.61% |
| 2020 Q1 | -197.38 Million USD | -3.17% |
| 2020 FY | -201.95 Million USD | -5.56% |
| 2020 Q4 | -201.95 Million USD | 0.77% |
| 2020 Q3 | -203.52 Million USD | 0.02% |
| 2020 Q2 | -203.57 Million USD | -3.13% |
| 2019 Q1 | -183.25 Million USD | 6.8% |
| 2019 FY | -191.32 Million USD | 2.7% |
| 2019 Q4 | -191.32 Million USD | -28.56% |
| 2019 Q3 | -148.81 Million USD | 28.28% |
| 2019 Q2 | -207.48 Million USD | -13.22% |
| 2018 Q3 | -176.28 Million USD | -5.97% |
| 2018 Q4 | -196.63 Million USD | -11.55% |
| 2018 FY | -196.63 Million USD | -37.55% |
| 2018 Q1 | -154.28 Million USD | -7.93% |
| 2018 Q2 | -166.34 Million USD | -7.82% |
| 2017 Q4 | -142.95 Million USD | -10.22% |
| 2017 Q2 | -114.71 Million USD | -9.14% |
| 2017 Q1 | -105.1 Million USD | -13.2% |
| 2017 Q3 | -129.69 Million USD | -13.06% |
| 2017 FY | -142.95 Million USD | -53.96% |
| 2016 Q2 | -84.34 Million USD | -16.88% |
| 2016 FY | -92.85 Million USD | -41.13% |
| 2016 Q1 | -72.16 Million USD | -9.68% |
| 2016 Q4 | -92.85 Million USD | -8.06% |
| 2016 Q3 | -85.92 Million USD | -1.88% |
| 2015 Q1 | -60.56 Million USD | -7.72% |
| 2015 FY | -65.79 Million USD | -17.02% |
| 2015 Q4 | -65.79 Million USD | -20.28% |
| 2015 Q3 | -54.69 Million USD | -6.51% |
| 2015 Q2 | -51.35 Million USD | 15.2% |
| 2014 Q2 | -55.63 Million USD | -10.47% |
| 2014 Q1 | -50.36 Million USD | -1653.52% |
| 2014 FY | -56.22 Million USD | -1857.59% |
| 2014 Q4 | -56.22 Million USD | -1.3% |
| 2014 Q3 | -55.5 Million USD | 0.24% |
| 2013 Q2 | -5.17 Million USD | -134.26% |
| 2013 Q3 | -5.03 Million USD | 2.8% |
| 2013 FY | -2.87 Million USD | 53.5% |
| 2013 Q1 | 15.11 Million USD | 344.69% |
| 2013 Q4 | -2.87 Million USD | 42.93% |
| 2012 FY | -6.17 Million USD | -207.92% |
| 2012 Q4 | -6.17 Million USD | 0.0% |
| 2011 FY | 5.72 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 482.427% |
| BrainsWay Ltd. | -10.32 Million USD | -903.576% |
| Cerus Corporation | 84.35 Million USD | 222.782% |
| Envoy Medical, Inc. | -3.81 Million USD | -2615.496% |
| electroCore, Inc. | -9.95 Million USD | -940.372% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -1920.859% |
| IceCure Medical Ltd | -9.93 Million USD | -942.571% |
| OrthoPediatrics Corp. | -9.26 Million USD | -1017.611% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -2744.521% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -690.782% |
| MaxCyte, Inc. | -27.76 Million USD | -273.047% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -1915.709% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -17888.006% |
| Orthofix Medical Inc. | 96.44 Million USD | 207.39% |
| PAVmed Inc | 29.08 Million USD | 456.079% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -511.423% |
| RxSight, Inc. | -6.68 Million USD | -1450.434% |
| Sight Sciences, Inc. | -102.71 Million USD | -0.831% |
| SI-BONE, Inc. | 5.72 Million USD | 1910.33% |
| TELA Bio, Inc. | -3.94 Million USD | -2522.664% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 280.682% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 29523.011% |
| Acutus Medical, Inc. | 12.27 Million USD | 943.464% |
| Talis Biomedical Corporation | -57.06 Million USD | -81.496% |
| Spectral AI, Inc. | -3.5 Million USD | -2858.269% |
| Nano-X Imaging Ltd. | -48.02 Million USD | -115.647% |
| CVRx, Inc. | -59.95 Million USD | -72.742% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 5319.83% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 8206.293% |
| Bioventus Inc. | 372.51 Million USD | 127.803% |
| Venus Concept Inc. | 74.3 Million USD | 239.391% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -917.177% |
| LivaNova PLC | 62.53 Million USD | 265.626% |
| 908 Devices Inc. | -115.09 Million USD | 10.015% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 132.294% |
| Nemaura Medical Inc. | 9.92 Million USD | 1143.515% |
| NeuroPace, Inc. | 54.33 Million USD | 290.605% |
| LENSAR, Inc. | -18.31 Million USD | -465.58% |
| Apyx Medical Corporation | -5.15 Million USD | -1910.658% |
| Cutera, Inc. | 288.3 Million USD | 135.924% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 1478.164% |
| BioSig Technologies, Inc. | 262 Thousand USD | 39630.153% |
| Anika Therapeutics, Inc. | -43.83 Million USD | -136.297% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -1025.872% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 107.37% |
| Axonics, Inc. | -77.19 Million USD | -34.167% |
| Outset Medical, Inc. | 67.67 Million USD | 253.03% |
| IRIDEX Corporation | -4.28 Million USD | -2315.322% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 41.821% |
| IRadimed Corporation | -47.71 Million USD | -117.039% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -3322.637% |
| INVO Bioscience, Inc. | 8.45 Million USD | 1325.504% |
| Telesis Bio, Inc. | 32.63 Million USD | 417.356% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -4039.23% |
| Varex Imaging Corporation | 316.9 Million USD | 132.682% |
| Quipt Home Medical Corp. | 81.73 Million USD | 226.714% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -3622.825% |
| Pulmonx Corporation | -42.36 Million USD | -144.497% |
| Dynatronics Corporation | 6.2 Million USD | 1769.382% |
| Modular Medical, Inc. | -8.04 Million USD | -1187.851% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -2310.263% |
| Semler Scientific, Inc. | -57.13 Million USD | -81.287% |
| InMode Ltd. | -135.39 Million USD | 23.505% |
| Bruker Corporation | 891.3 Million USD | 111.62% |
| Cytosorbents Corporation | 4.18 Million USD | 2576.533% |
| DexCom, Inc. | 2.02 Billion USD | 105.108% |
| Align Technology, Inc. | -840.47 Million USD | 87.677% |
| Viveve Medical, Inc. | -13.81 Million USD | -649.794% |
| ZimVie Inc. | 450.41 Million USD | 122.994% |
| Movano Inc. | -5.86 Million USD | -1665.581% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 22.972% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -17888.006% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 5319.83% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 129.027% |
| Profound Medical Corp. | -18.17 Million USD | -469.733% |
| Insulet Corporation | 798.1 Million USD | 112.977% |
| enVVeno Medical Corporation | -2.21 Million USD | -4569.477% |
| Surmodics, Inc. | -12.01 Million USD | -762.069% |
| iCAD, Inc. | -21.2 Million USD | -388.326% |
| Nuwellis, Inc. | -2.81 Million USD | -3573.962% |
| Biotricity, Inc. | 23.09 Million USD | 548.492% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 210.59% |
| Aethlon Medical, Inc. | -4.5 Million USD | -2200.684% |
| InspireMD, Inc. | -8.04 Million USD | -1187.371% |
| PAVmed Inc. | 29.08 Million USD | 456.079% |
| BIOLASE, Inc. | 11.34 Million USD | 1012.985% |
| Beyond Air, Inc. | 6.22 Million USD | 1762.691% |
| FONAR Corporation | -14.66 Million USD | -606.217% |
| AxoGen, Inc. | 32.26 Million USD | 420.985% |
| Vivani Medical, Inc. | 42 Thousand USD | 246692.857% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -871.749% |
| Inari Medical, Inc. | -7.16 Million USD | -1346.292% |
| UFP Technologies, Inc. | 40.77 Million USD | 354.007% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 3475.096% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -2070.662% |
| Tenon Medical, Inc. | -1.25 Million USD | -8152.51% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -1261.675% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -768.408% |
| AdaptHealth Corp. | 2.21 Billion USD | 104.67% |
| Sintx Technologies, Inc. | 905 Thousand USD | 11544.088% |
| NanoVibronix, Inc. | -3.27 Million USD | -3059.518% |
| Quanterix Corporation | -132.95 Million USD | 22.104% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -3622.825% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -363.085% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 113.741% |
| TransMedics Group, Inc. | 121.13 Million USD | 185.5% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -295.604% |
| NeuroMetrix, Inc. | -1.49 Million USD | -6845.952% |
| Hyperfine, Inc. | -75.61 Million USD | -36.962% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 168.053% |
| Biomerica, Inc. | -3.38 Million USD | -2959.645% |
| Bone Biologics Corporation | -3.02 Million USD | -3321.994% |
| AVITA Medical, Inc. | -26.23 Million USD | -294.825% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -5533.615% |
| Silk Road Medical, Inc | 64.42 Million USD | 260.764% |